SASPIPHI LIMITED
Company number 15540156 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£329,894
Balance sheet as at 2025-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2024-03-04
- Employees
- 2 (2025 accounts)
- Registered office
- Future Business Centre Cambridge Campus, Kings Hedges Road, Cambridge, Cambridgeshire, England, CB4 2HY
- Postcode
- CB4 2HY
- Capital
- 40 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-03-03
- Next due by
- 2027-03-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 1 resigned
Anne Mary Louise, Dr BARNARD
Director
Richard NAGLE
Director
Group structure
Controlled by Phagespace (96906970) — since 2024-08-22
From persons-with-significant-control filings on the public register.
Contact details
- Website
- saspiphi.com
SASPjects use engineered bacteriophages as precision antimicrobials, delivering a gene encoding a toxin (SASP) to target bacteria e.g. P. aeruginosa, S. aureus
Previous company names
| Name | Date changed |
|---|---|
| PTHRA LIMITED | 2024-10-21 |
Competitors Cambridge
This company ranks 74 among research and experimental development on biotechnology in Cambridge.